Literature DB >> 10194125

Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis.

X Mariette1.   

Abstract

The occurrence of non Hodgkin's lymphoma (NHL) is the most serious complication of Sjögren's syndrome (SS). Taking the opportunity to study 16 patients with lymphoma and an underlying SS, we performed a review of literature concerning SS and lymphoma and made an hypothesis on the physiopathology of lymphoproliferation in patients with SS. Lymphomas occurring in patients with SS are in most cases low grade marginal zone lymphomas (MZL). They arise frequently in mucosal extranodal sites, not only in the salivary glands but also the stomach and the lung. These lymphomas are not associated with viruses including hepatitis C virus (HCV), Epstein-Barr virus, human herpes virus 8 or human T lymphotropic virus-I, known to be present in other types of lymphomas. Some of the translocations or mutations of oncogenes or anti-oncogenes described in other lymphomas are also detected in SS-associated lymphomas. Lymphomas complicating SS share a number of characteristics with lymphomas complicating HCV infection. We make the assumption that, in both diseases, the first event of lymphomagenesis is the chronic stimulation, on the site of the disease, of polyclonal B-cells secreting rheumatoid factor (RF). Then, these RF B-cells may become monoclonal and disseminate in other organs. The monoclonal secreted RF complexed with polyclonal IgG may cryoprecipitate. The following step would be a chromosomal abnormality (e.g. trisomy 3) which would confer to these cells a low grade B-cell lymphoma compartment. A last event (e.g. mutation of p53) could transform this low grade B-cell lymphoma into a high grade large B-cell lymphoma. If this hypothesis was correct, most of B-cell lymphomas associated with SS should have a surface immunoglobulin with RF activity and should grow through an auto-antigen driven process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194125     DOI: 10.3109/10428199909093729

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  9 in total

Review 1.  Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.

Authors:  Michael Voulgarelis; Fotini N Skopouli
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 2.  Cytokines in Sjögren's syndrome.

Authors:  N Roescher; P P Tak; G G Illei
Journal:  Oral Dis       Date:  2009-06-10       Impact factor: 3.511

Review 3.  Lymphoproliferation in autoimmunity and Sjögren's syndrome.

Authors:  Michalis Voulgarelis; Haralampos M Moutsopoulos
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

Review 4.  Clonality analysis of lymphoproliferative disorders in patients with Sjögren's syndrome.

Authors:  L Dong; Y Masaki; T Takegami; Z-X Jin; C-R Huang; T Fukushima; T Sawaki; T Kawanami; T Saeki; K Kitagawa; S Sugai; T Okazaki; Y Hirose; H Umehara
Journal:  Clin Exp Immunol       Date:  2007-11       Impact factor: 4.330

5.  Rare case of Primary Pulmonary Extranodal Non-Hodgkin's Lymphoma in a Patient with Sjogren's Syndrome: Role of FDG-PET/CT in the Initial Staging and Evaluating Response to Treatment.

Authors:  Gonca Bural; Judith Joyce; James Ohr
Journal:  Mol Imaging Radionucl Ther       Date:  2012-12-20

6.  HCV infection enhances Th17 commitment, which could affect the pathogenesis of autoimmune diseases.

Authors:  Yasuteru Kondo; Masashi Ninomiya; Osamu Kimura; Keigo Machida; Ryo Funayama; Takeshi Nagashima; Koju Kobayashi; Eiji Kakazu; Takanobu Kato; Keiko Nakayama; Michael M C Lai; Tooru Shimosegawa
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

7.  Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.

Authors:  D Dey; E Kenu; D A Isenberg
Journal:  Lupus       Date:  2013-07-15       Impact factor: 2.911

8.  Gastrointestinal disease in Sjogren's syndrome: related to food hypersensitivities.

Authors:  Christine Kim-Lee; Lakshmanan Suresh; Julian L Ambrus
Journal:  Springerplus       Date:  2015-12-12

9.  Clinical manifestations of autoimmune disease-related non-Hodgkin lymphoma: a Korean single-center, retrospective clinical study.

Authors:  Young-Woo Jeon; Jae-Ho Yoon; Sung-Eun Lee; Ki-Seong Eom; Yoo-Jin Kim; Hee-Je Kim; Seok Lee; Chang-Ki Min; Jong Wook Lee; Woo-Sung Min; Seok-Goo Cho
Journal:  Korean J Intern Med       Date:  2016-07-07       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.